Osteoporosis (OP), a bone disease, emerges once bone mass and mineral density decline or whenever the composition and rigidity of bones alter. This may result in a loss of bone density and a higher likelihood of fractures. Though it can happen at any stage of life, the probability of getting the condition rises with age. Many women experience the onset of the condition approximately 1 or 2 months prior to menopause. Due to the fact that there are frequently no indications unless a bone is shattered, it has been referred to as a silent disorder. Spine breakage indications comprise excruciating pain in the back, a loss in height, or spine abnormalities like a slumped or crooked position called kyphosis. Recurrent fractures are to be avoided with preventive measures and treatment. In patients with elevated risks, modifications to lifestyles ought to be advised. Quantitative ultrasound (QUS) and dual-energy X-ray absorptiometry (DXA) are the two diagnostic techniques. The most effective technique for recognizing OP is DXA. A significant predictor of the probability that bones will break down is bone mineral density (BMD). Additionally, it is helpful in determining osteopenia (OPA) and OP and evaluating the efficacy of therapies intended to stop losing bones. OP can be inhibited from progressing more effectively the sooner it is recognized and addressed. The developed BMD disease prediction tool allows for the quick diagnosis and classification of those suffering as normal, OPA, or OP.